12 May, 2025AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
18 March, 2025Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
4 March, 2025Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
26 February, 2025NanoPhoria Bioscience awarded €17.5 M from European Innovation Council’s accelerator program